rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
29
|
pubmed:dateCreated |
1993-12-28
|
pubmed:abstractText |
Subsequent of the discovery that RNA can have site specific cleavage activity, there has been a great deal of interest in the design and testing of trans-acting catalytic RNAs as therapeutic agents. We have chemically synthesized and experimentally analyzed chimeric DNA-RNA ribozymes in which the catalytic center remains as RNA.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0261-3166
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
175-6
|
pubmed:dateRevised |
2000-12-18
|
pubmed:meshHeading |
pubmed-meshheading:8247757-Base Sequence,
pubmed-meshheading:8247757-Catalysis,
pubmed-meshheading:8247757-Hydrolysis,
pubmed-meshheading:8247757-Hydroxyl Radical,
pubmed-meshheading:8247757-Kinetics,
pubmed-meshheading:8247757-Molecular Sequence Data,
pubmed-meshheading:8247757-Nucleic Acid Conformation,
pubmed-meshheading:8247757-Purines,
pubmed-meshheading:8247757-Pyrimidines,
pubmed-meshheading:8247757-RNA, Catalytic
|
pubmed:year |
1993
|
pubmed:articleTitle |
Importance of specific purine-pyrimidine amino and hydroxyl groups for efficient cleavage by a hammerhead ribozyme.
|
pubmed:affiliation |
Department of Industrial Chemistry, Chiba Institute of Technology, Japan.
|
pubmed:publicationType |
Journal Article
|